Loading...

FOXP3 Fix/Perm Buffer Set

Pricing & Availability
Regulatory Status
RUO
Other Names
FOXP3 Fixation/Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
A_FoxP3_True-Nuclear_Flow_Chart_060117
Whole blood was stained with human CD3 APC/Cyanine7 (blue and red) or APC/Fire™ 750 (green and purple), then lysed, washed and fixed under the following conditions: A) Fixed with FOXP3 fix buffer followed by permeabilization with FOXP3 perm buffer (purple and red). B) Fixed with True-Nuclear™ fix buffer, then permeabilized with True-Nuclear™ perm buffer (green and blue). Compensation requirements between the APC and APC/Cyanine7 channels increased significantly for the FoxP3 Fix/Perm buffer set versus the True-Nuclear™ transcription factor buffer set for both APC/Cyanine7 and APC/Fire™ 750.
  • A_FoxP3_True-Nuclear_Flow_Chart_060117
    Whole blood was stained with human CD3 APC/Cyanine7 (blue and red) or APC/Fire™ 750 (green and purple), then lysed, washed and fixed under the following conditions: A) Fixed with FOXP3 fix buffer followed by permeabilization with FOXP3 perm buffer (purple and red). B) Fixed with True-Nuclear™ fix buffer, then permeabilized with True-Nuclear™ perm buffer (green and blue). Compensation requirements between the APC and APC/Cyanine7 channels increased significantly for the FoxP3 Fix/Perm buffer set versus the True-Nuclear™ transcription factor buffer set for both APC/Cyanine7 and APC/Fire™ 750.
  • B_FoxP3_True-Nuclear_BALBC_Plots_053117
    BALB/c spleen cells were cultured for four days in presence of LPS. Then the cells were stained with CD45R/B220 PE, followed by fixation and permeabilization with either FoxP3 Fix/Perm Buffer (top) or True-Nuclear™ Transcription Factor Buffer Set (bottom), and staining with Blimp-1 (clone 5E7) Alexa Fluor® 647. Data shown was gated on live cells using Zombie Aqua™ fixable viability dye.
  • C_FoxP3_True-Nuclear_HuPMBC_Plots_053117
    Human peripheral blood lymphocytes were surface stained with CD4 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set (Cat. No. 424401). Cells were then stained with FOXP3 (clone 206D) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
Cat # Size Price Quantity Check Availability Save
421403 100 tests 141 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

BioLegend's FOXP3 Fix/Perm Buffer Set has been specially formulated for intracellular staining FOXP3 with minimum effect on the surface fluorochrome staining. It contains one 30 ml 4X concentrated FOXP3 Fix/Perm buffer (Cat. No. 421401) and one 25 mL 10X concentrated FOXP3 Perm buffer (Cat. No. 421402). The FOXP3 Fix/Perm buffer (4X) must be freshly diluted to 1X working solution with PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2) prior to staining procedures. e.g. Dilute one (1) part FOXP3 Fix/Perm buffer (4X) to three (3) parts PBS. The FOXP3 Perm buffer (10X) should be diluted to 1X working solution with PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2) prior to staining procedures. e.g. Dilute one (1) part FOXP3 Perm buffer(10X) to nine (9) parts PBS.

Warning: The FOXP3 Buffer Set can have a deleterious effect on tandem fluorophores (particularly APC/Cyanine7) in a multicolor assay, causing an increase in compensation into the APC channel. If your panel contains a surface stain with an antibody conjugated to a tandem fluorophore, consider using the True-Nuclear™ Transcription Factor Buffer Set (Cat. No. 424401) instead, which provides a clearer resolution of FoxP3 as well as other nuclear transcription factors. Please refer to the data provided here.

Caution: The FOXP3 Fix/Perm buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contact.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C. Do not freeze.

To obtain lot-specific expiration date, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)

This product has a shelf-life of 12 months or less. Please contact our technical support team for lot specific CoA and expiration date inquiries of this product.
Application

ICFC - Quality tested
Recommended Usage

The FOXP3 Fix/Perm buffer(4X) must be diluted to 1X working solution with PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2) prior to staining procedures. e.g. Dilute one (1) part FOXP3 Fix/Perm buffer(4X) to three (3) parts PBS. The FOXP3 Perm buffer (10X) should be diluted to 1X working solution with PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2) prior to staining procedures. e.g. Dilute one (1) part FOXP3 Perm buffer(10X) to nine (9) parts PBS.

NOTE: The FOXP3 Perm buffer (10X) may have crystalization or precipitation oberserved when it is stored at 2-8°C, however, it's normal and does not affect the buffer performance. If there is a heavy precipitation observed after diluted to 1X working solution, it can be filtered to clarify the solution.

Application Notes

NOTE: For flow cytometric staining, True-Nuclear™ Transcription Factor Buffer Set (Cat. No. 424401) offers improved staining and is highly recommended over the Foxp3 Fix/Perm Buffer Set (Cat. No. 421403).

FOXP3 Intracellular Staining Procedures:
1. Perform cell surface staining as described in BioLegend's Cell Surface Immunofluorescence Staining Protocol.
2. Add 1 ml of 1X BioLegend's FOXP3 Fix/Perm solution to each tube, vortex and incubate at room temperature in the dark for 20 minutes, then spin down the cells and remove the supernatant.
3. Wash once with cell staining buffer (Cat. No. 420201) by spin at 250Xg for 5 minutes and remove the supernatant.
4. Wash once with 1ml 1X BioLegend's FOXP3 Perm buffer.
5. Re-suspend cells in 1ml 1X BioLegend's FOXP3 Perm buffer, incubate at room temperature in the dark for 15 minutes, spin down cells and discard the supernatant, then resuspend the pellet in 100 ul of 1X BioLegend's FOXP3 Perm buffer.
6. Add appropriate amount of flurochrome conjugated anti-FOXP3 antibody and incubate at room temperature in the dark for 30 minutes.
7. Wash twice with cell staining buffer, and resuspend in 0.5ml cell staining buffer then analyze with flow cytometer with appropriate instrument setting.

Application References

(PubMed link indicates BioLegend citation)
  1. Yang ZZ, et al. 2006. Blood 107:3639. PubMed
  2. Groh V, et al. 2006. Nat. Immunol. 7:755. PubMed
  3. Bamias G, et al. 2007. J. Immunol. 178:1809. PubMed
  4. MacDonald K PA, et al. 2007. Blood doi:10.1182/blood-2007-01-067249. PubMed
  5. Müller M, et al. 2007. J. Immunol. 179:2774.
  6. Dang Y,et al.2007.Clin Cancer Res.13:1883. PubMed
  7. Basu S, et al. 2008. J. Immunol. 180:5974. PubMed
  8. Takamura S, et al. 2010. J. Immunol. 184:4696. PubMed
  9. Beavis, PA., et al. 2011. PNAS. 108:16717. PubMed
  10. Kling J, et al. 2013. Exp Parasitol. 129:270. PubMed
  11. Troutman TD, et al. 2012. PNAS. 109:273. PubMed
  12. Faustman DL, et al. 2012. PLoS One. 7:e41756. PubMed
  13. Liu Y, et al. 2012. Food Chem Toxicol. 50:1920. PubMed
  14. Kawamoto N, et al. 2013. Int Immunol. 25:53. PubMed
  15. Morandi B, et al. 2013. J. Immunol. 191:4858. PubMed
  16. Shiba T, et al. 2014. Toxicol Appl Pharmacol. 274:191. PubMed
  17. Cook KW, et al. 2014. Gut. PubMed
  18. Shibuya KC, et al. 2014. PLoS One. 9:96565. PubMed
  19. Cecil DL, et al. 2014. Cancer Res. 74:2710. PubMed
  20. Linnerbauer S, et al. 2014. PLoS Pathog. 10:1004068. PubMed
  21. Basu S, et al. 2015. J Leukoc Biol. 97:279. PubMed
Product Citations
  1. Danileviciute E, et al. 2022. Nat Metab. 4:589. PubMed
  2. Freimer JW, et al. 2022. Nat Genet. 54:1133. PubMed
  3. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  4. Fetit R, et al. 2023. Development. 150:. PubMed
  5. Jin J, et al. 2023. Nat Aging. 3:600. PubMed
  6. Chiu H, et al. 2021. iScience. 24:102748. PubMed
  7. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  8. Jin J, et al. 2021. Sci Immunol. 6:. PubMed
  9. Hippen KL, et al. 2021. Cytotherapy. 23:704. PubMed
  10. Ren J, et al. 2022. Proc Natl Acad Sci U S A. 119:e2117401119. PubMed
  11. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  12. Wang Z, et al. 2022. Proc Natl Acad Sci U S A. 119:e2201899119. PubMed
  13. Zhou Y, et al. 2022. Evid Based Complement Alternat Med. 2022:2197763. PubMed
  14. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  15. Shibuya K, et al. 2014. PLoS One. 9:96565. PubMed
  16. Williams JW, et al. 2020. Nat Immunol. 1194:21. PubMed
  17. Singh AK, et al. 2017. JCI Insight. 2:e94275. PubMed
  18. Yang D, et al. 2016. PLoS Negl Trop Dis. 10: 0004335. PubMed
  19. Puc I, et al. 2022. Int J Mol Sci. 23:. PubMed
  20. Song J, et al. 2022. Clin Transl Med. 12:e992. PubMed
  21. Zemek RM, et al. 2020. Nat Protoc. 15:1628. PubMed
  22. Zbinden A, et al. 2021. Adv Sci (Weinh). 2002500:8. PubMed
  23. Mizraji G, et al. 2017. Cell Rep. 18(2):419-431. PubMed
  24. Troutman T, et al. 2012. Proc Natl Acad Sci U S A. 109:273. PubMed
  25. Kawamoto N, et al. 2013. Int Immunol. 25:53. PubMed
  26. Kamigaki T, et al. 2015. Anticancer Res. 35: 4535-4543. PubMed
  27. Fernandez SV, et al. 2020. Breast Cancer Res. 1.009722222. PubMed
  28. Bamias G, et al. 2007. J Immunol. 178:1809. PubMed
  29. Cook K, et al. 2014. Gut. . PubMed
  30. Dang Y, et al. 2007. Clin Cancer Res . 1.932638889. PubMed
  31. Yang Z, et al. 2006. Blood. 107:3639. PubMed
  32. Morandi B, et al. 2013. J Immunol. 191:4858. PubMed
  33. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  34. Zhao XY, et al. 2020. Sci Adv. 6:eaay6191. PubMed
  35. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  36. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  37. Takamura S, et al. 2010. J Immunol. 184:4696. PubMed
  38. Brennan CA, et al. 2021. Gut Microbes. 13:1987780. PubMed
  39. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  40. Basu S, et al. 2015. J Leukoc Biol. 97:279. PubMed
  41. Haller M, et al. 2016. Diabetes. 65(12):3765-3775. PubMed
  42. Beavis P, et al. 2011. Proc Natl Acad Sci U S A. 108:16717. PubMed
  43. Greaney SK, et al. 2020. Cancer Immunol Res. 0.504166667. PubMed
  44. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  45. Pfirrmann V, et al. 2015. Cytotherapy. 17: 1139-1151. PubMed
  46. Cecil D, et al. 2014. Cancer Res. 74:2710. PubMed
  47. Liu Y, et al. 2012. Food Chem Toxicol. 50:1920. PubMed
  48. Basu S, et al. 2008. J Immunol. 180:5794. PubMed
  49. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  50. Keefe RC, et al. 2021. Sci Rep. 11:14933. PubMed
  51. Zhou Q, et al. 2015. J Immunol. 195: 2493-250. PubMed
  52. Huang S, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.75. PubMed
  53. de Winde CM, et al. 2021. J Cell Sci. 134: . PubMed
  54. Kwek S, et al. 2015. Cancer Immunol Res. 3: 1008-1016. PubMed
  55. Shiba T, et al. 2014. Toxicol Appl Pharmacol. 274:191. PubMed
  56. Li H, et al. 2015. Reproduction. 150: 417-427. PubMed
  57. Urueña C, et al. 2022. Front Med (Lausanne). 9:991873. PubMed
  58. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  59. Chiaro J, et al. 2021. Cancer Immunol Res. 9:981. PubMed
  60. Andersen K, et al. 2017. J Am Soc Nephrol. 28:76. PubMed
  61. Oliveira G, et al. 2015. Sci Transl Med. 7: 317ra198. PubMed
  62. MacDonald K, et al. 2007. Blood . 109:5049. PubMed
  63. Méndez-Lagares G, et al. 2021. J Clin Invest. 131:e148542. PubMed
  64. Solleiro-Villavicencio H, et al. 2015. Clin Immunol. . PubMed
  65. Martini E, et al. 2016. Cell Rep. 14:1062-1073. PubMed
  66. Jacobs H, et al. 2016. J Immunol. 196: 3525 - 3531. PubMed
  67. Zheng D, et al. 2022. Front Immunol. 13:808347. PubMed
  68. Mishra P, et al. 2016. PLoS Negl Trop Dis. 10: 0004787. PubMed
  69. Weber A, et al. 2016. Infect Immun . 84: 1413 - 1423. PubMed
  70. Linnerbauer S, et al. 2014. PLoS Pathog. 10:1004068. PubMed
  71. Kling J, et al. 2011. Exp Parasitol. 129:270. PubMed
  72. Okagawa T, et al. 2016. Infect Immun . 84: 77 - 89. PubMed
  73. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  74. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  75. Okano T, et al. 2017. Sci Rep. 7:42412. PubMed
  76. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  77. Javed A, et al. 2015. PLoS One. 10: 0142086. PubMed
  78. Li Y, et al. 2015. J Immunol. 195: 1591 - 1598. PubMed
  79. Faustman D, et al. 2012. PLoS One. 7:e41756. PubMed

Antigen Details

Cell Type
Tregs
Biology Area
Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Gene ID
NA
Specificity (DOES NOT SHOW ON TDS):
FOXP3
Specificity Alt (DOES NOT SHOW ON TDS):
FOXP3
App Abbreviation (DOES NOT SHOW ON TDS):
ICFC

Related FAQs

Can I stain whole blood with anti-FOXP3 using your Foxp3 staining kit?

It is not recommended. It is best to use PBMCs for this testing.

Can FOXP3 be costained with cytokines?

The larger holes created by the nuclear permeabilization required for FOXP3 may allow cytokines to leak out of the cell, making it harder to detect lowly-expressed cytokines. You may have to use a control where the cells are only permeabilized through the cell membrane.

Go To Top Version: 4    Revision Date: 09.16.2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account